These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18558304)

  • 101. Cinacalcet for cardiovascular disease in patients undergoing dialysis.
    Urena-Torres P; Prié D; Souberbielle JC
    N Engl J Med; 2013 May; 368(19):1842-3. PubMed ID: 23656654
    [No Abstract]   [Full Text] [Related]  

  • 102. Cinacalcet for cardiovascular disease in patients undergoing dialysis.
    Chertow GM; Parfrey PS
    N Engl J Med; 2013 May; 368(19):1844-5. PubMed ID: 23656653
    [No Abstract]   [Full Text] [Related]  

  • 103. Clinical remission as measured by a decrease in intact parathyroid hormone levels after administration of cinacalcet in patients with severe hyperparathyroidism.
    Battistella M; Hamandi B; Pui C; Oreopoulos D; Richardson R; Jassal SV
    Nephrol Dial Transplant; 2008 Feb; 23(2):773-4. PubMed ID: 17977873
    [No Abstract]   [Full Text] [Related]  

  • 104. Medical therapy of secondary hyperparathyroidism in chronic kidney disease: old and new drugs.
    de Francisco AL
    Expert Opin Pharmacother; 2006 Nov; 7(16):2215-24. PubMed ID: 17059378
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Use of denosumab to treat refractory hypercalcemia in a peritoneal dialysis patient with immobilization and tertiary hyperparathyroidism.
    Pratt RM; West ML; Tennankore KK
    Perit Dial Int; 2020 Jan; 40(1):103-106. PubMed ID: 32063140
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Multidisciplinary treatment. A therapeutic option to treat calciphylaxis.
    Conde Rivera O; Camba Caride M; Novoa Fernández E; Borrajo Prol M; Santos Nores J; Iglesias Lamas E; López Alarcóon W
    Nefrologia; 2011; 31(5):614-6. PubMed ID: 21959736
    [No Abstract]   [Full Text] [Related]  

  • 107. New agents for the treatment of renal osteodystrophy.
    Ledger S
    CANNT J; 2004; 14(4):16-21; quiz 21-2. PubMed ID: 15673151
    [No Abstract]   [Full Text] [Related]  

  • 108. [When evidence does not correspond to cost-effectiveness].
    Vernaglione L
    G Ital Nefrol; 2007; 24(6):493. PubMed ID: 18278749
    [No Abstract]   [Full Text] [Related]  

  • 109. Brown tumour involving the orbit: case report and review of the literature.
    Borbolla-Pertierra AM; Guinto-Arcos E; Rodríguez-Reyes A; Graue-Moreno G; Olvera-Morales O
    Can J Ophthalmol; 2016 Aug; 51(4):e125-e127. PubMed ID: 27521680
    [No Abstract]   [Full Text] [Related]  

  • 110. Secondary hyperparathyroidism in chronic dialysis patients.
    Gai M; Cantaluppi V
    Blood Purif; 2012; 34(3-4):211; author reply 212. PubMed ID: 23095735
    [No Abstract]   [Full Text] [Related]  

  • 111. Progressive renal bone disease--an assessment of long-term therapy with vitamin D analogues.
    MacDonald PJ; Junor BJ; Fraser RA; Smith FW; Ettinger KV; Cutto GR; Edward N; MacLeod M
    Scott Med J; 1979 Jan; 24(1):87-8. PubMed ID: 227053
    [No Abstract]   [Full Text] [Related]  

  • 112. Evolution of secondary hyperparathyroidism after renal transplantation.
    Koch Nogueira PC; David L; Cochat P
    Pediatr Nephrol; 2000 Apr; 14(4):342-6. PubMed ID: 10775082
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Toxic effects of aluminum in end-stage renal disease: discussion of a case.
    Coburn JW; Norris KC; Sherrard DJ; Bia M; Llach F; Alfrey AC; Slatopolsky E
    Am J Kidney Dis; 1988 Sep; 12(3):171-84. PubMed ID: 3414675
    [No Abstract]   [Full Text] [Related]  

  • 114. [Fragility Fractures in Hemodialysis Patients. Loss of kidney function and system for calcium homeostasis.].
    Komaba H
    Clin Calcium; 2018; 28(8):1057-1063. PubMed ID: 30049914
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Evaluating the safety and rationale for cinacalcet posttransplant hyperparathyroidism and hypercalcemia.
    Coyne DW; Delos Santos R
    Am J Transplant; 2014 Nov; 14(11):2446-7. PubMed ID: 25223316
    [No Abstract]   [Full Text] [Related]  

  • 116. Prolonged hyperalimentation in catabolic chronic dialysis therapy patients.
    Piraino AJ; Firpo JJ; Powers DV
    JPEN J Parenter Enteral Nutr; 1981; 5(6):463-77. PubMed ID: 6801281
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Secondary hyperparathyroidism in acute renal failure from rhabdomyolysis.
    Bitran JD
    Ann Intern Med; 1976 Nov; 85(5):679. PubMed ID: 984627
    [No Abstract]   [Full Text] [Related]  

  • 118. Update in nephrology. Highlights from the 36th Annual Meeting of the American Society of Nephrology.
    Cases A
    Drugs Today (Barc); 2004 Jan; 40(1):81-92. PubMed ID: 14988772
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Musculoskeletal complications after renal transplantation: pathogenesis and treatment.
    Julian BA; Quarles LD; Niemann KM
    Am J Kidney Dis; 1992 Feb; 19(2):99-120. PubMed ID: 1739106
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Management of metabolic bone disease in kidney transplant recipients.
    Zhang R; Alper B; Simon E; Florman S; Slakey D
    Am J Med Sci; 2008 Feb; 335(2):120-5. PubMed ID: 18277120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.